Dr. Rahhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Retina Vitreous Associates Medical Group
9001 Wilshire Blvd, Ste 301
Beverly Hills, CA 90211Phone+1 310-854-6201- Is this information wrong?
Education & Training
- University of California (San Diego) Medical CenterFellowship, Surgical Retina and Vitreous, 1994 - 1996
- New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1991 - 1994
- Olive View/UCLA Medical CenterInternship, Internal Medicine, 1990 - 1991
- Uconn School Of MedicineClass of 1990
- University of PennsylvaniaBA, Biochemistry, 1982 - 1986
Certifications & Licensure
- CA State Medical License 1994 - 2025
- NY State Medical License 1991 - 2001
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- The Retina Society
- American Society of Retina Specialists
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
- Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD Start of enrollment: 2016 Feb 16
- TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Publications & Presentations
PubMed
- Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.Humayun, M., Clegg, D., Dayan, M., Kashani, A., Rahhal, F., Avery, R., Salehi-Had, H., Chen, S., Chan, C., Palejwala, N., Ingram, A., Mitra, D., Pennington, B., Hinman...> ;Ophthalmology. 2023 Dec 30
- 17 citationsSurvival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.Amir H Kashani, Jane S Lebkowski, David R Hinton, Danhong Zhu, Mohamed A Faynus, Sanford Chen, Firas M Rahhal, Robert L Avery, Hani Salehi-Had, Clement Chan, Neal Pale...> ;Stem Cell Reports. 2022 Mar 8
- 24 citationsOne-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular DegenerationAmir H. Kashani, Jane Lebkowski, Firas M. Rahhal, Robert L. Avery, Hani Salehi-Had, Sanford Chen, Clement Chan, Neal V. Palejwala, April Ingram, Wei Dang, Chih-Min Lin...> ;Translational Vision Science & Technology. 2021 Aug 12
- Join now to see all
Press Mentions
- Virtual Clinical Day Recap: Outlook Therapeutics Joined by Drs. Mark Humayun and Firas Rahhal to Discuss Need for FDA-Approved Ophthalmic Bevacizumab and Status of ONS-5010May 27th, 2021
- Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed Wet AMD Treatment Landscape and ONS-5010/LYTENAVA™November 11th, 2020
Professional Memberships
- Fellow
Hospital Affiliations
- Good Samaritan HospitalLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: